Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31412 total
SO sits at the sharpest end of this week's real-economy signals. NRC reactor status data shows SO's nuclear output fell 10.0 standard deviations below its own history as of 28 October. That is an extreme outlier by any…
Boston Scientific took the heaviest analyst fire on Friday. Jefferies downgraded the stock from Buy to Hold. The firm cut its target from $60 to $46. Canaccord Genuity kept its Buy rating but slashed its own target…
The latest batch of insider filings, reported on 8 September 2026, shows a clear pattern: selling dominates, and the amounts are large. The headline trade belongs to Fosun Pharma Industrial, the promoter-group…
Short sellers added pressure across several mid-cap names this week. Data from ORTEX covering the seven days to 28 October shows the biggest moves among stocks with market caps above $500 million. CBRS (Cerebras…
China led all geographies this week by a wide margin. ETFs targeting Chinese equities pulled in $17.9B net over the past five days, a flow_imbalance score of 78.7 indicating strong buying pressure. That compares with…
Xylem has lost 17% in the past week. The stock closed Thursday at $90.76. Almost every analyst who covers it cut their target in the past 48 hours. And yet a board director spent nearly $1 million buying shares in the…
Four distinct data streams on NU converged this week, and the options market is telling a sharply different story from the short sellers. Short interest in Nu Holdings climbed 22% in a single week, reaching 4.1% of…
Intel crashed 23% overnight after its earnings miss. The move sharpened an already crowded short picture across semiconductors. SanDisk reports tonight after a 492% year-to-date run. Options expiries cluster around…
Earnings season is driving unusual options activity across several key names. Retail attention around the Goldman Sachs S&P 500 Premium Income ETF (GPIX) spiked 10 standard deviations above its own history in the week…
AAPL reports fiscal first-quarter results on November 2, arriving at the print with a complex data picture: the October 29 event that previous notes flagged as the key risk has now passed, and the snapshot captured…
RIGD short interest has dropped to its lowest level in at least a year, a move 2.1 standard deviations below the stock's typical weekly change, on the same day the company reports quarterly earnings. The lending market…
BACH.Y, the OTC-listed ADR of Bank of China Limited, reports today with the same low-pressure borrow environment that has characterised this listing for weeks. The lending picture is notably relaxed for a name heading…
TXAR reports its Q3 2026 results today with the stock up 16% over the past month, a sharp recovery that frames the question investors will want answered: whether the underlying business can support the move. The price…
SNDK is a pure-play NAND flash storage company reporting its latest quarterly results this evening, arriving at $1,330 after losing 22% over the past month and nearly a third of its value from the $1,887 September…
GE HealthCare Technologies gained 7% last week, more than three times the median move of its closest peers: STE, SYK, and ABT all rose between 2% and 3%, while BDX and ZBH added less than 2%. GEHC's short interest, at…
MAX heads into its November 2 earnings date having already reported Q3 results, with the stock up 20% on the day of the announcement and analysts lifting targets across the board to catch up with the move. The rally is…
Palantir Technologies reports Q3 results on November 2, arriving at the print with a striking divergence: a wave of analyst upgrades and target lifts in the past three weeks, a stock that has barely moved, and a peer…
BridgeBio Pharma is less shorted than its peer group heading into today's print, with short interest at 10.6% of the free float, while correlated names like NGNE surged 16.6% on the week and the peer median moved 4.3%…
Today brings the first major print. REGN reports this morning, with its Q3 earnings call already underway at 8:30am ET. The $80bn biomaker faces investor scrutiny over its Dupixent franchise outlook. Sunday evening…
HG reports Q3 results on October 30 with a notable insider selling trend adding a cautious undertone to an otherwise constructive analyst setup. The most distinctive signal heading into the print is what insiders have…
